USPTO serial 75889395
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
BLOOMINGTON, MN
ST. PAUL, MN
St. Paul, MN
St. Paul, MN
St. Paul, MN
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DEAN R. KARAU
DEAN R. KARAU FREDRIKSON & BYRON, PA200 S SIXTH STSUITE 4000MINNEAPOLIS, MN 55402| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; biochemicals, namely, precursors for in vitro genetic engineering use; biochemicals, namely, polypeptides for in vitro research use; biochemicals, namely, precursors for in vitro genetic engineering use; cells for scientific, laboratory or medical research; immunoassay test kits consisting primarily of chemical reagents for the quantification of proteins, peptides and polypeptides; immunoassay test kits consisting primarily of chemical reagents for the rapid isolation and activation of cells for scientific, laboratory or medical research; immunoassay test kits consisting primarily of chemical reagents for the isolation and activation of cells for medical or clinical use; Biochemicals, namely, protein epitopes for in vitro research use to induce immune responses with respect to cancer, infectious, allergic or autoimmune diseases; kits for in vitro synthesis of proteins comprised of reagents for scientific research use | SECTION 8 - CANCELLED | Apr 1, 1995 |
| 005 | Cells for medical or clinical use; immunoassay test kits consisting primarily of chemical reagents for the isolation and activation of cells for medical or clinical use | SECTION 8 - CANCELLED | Apr 1, 1995 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 6, 2012 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Nov 3, 2010 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Sep 8, 2010 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 25, 2007 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jun 21, 2007 | PLGL | ASSIGNED TO PARALEGAL | — |
| May 29, 2007 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| May 29, 2007 | PAPER RECEIVED | — | |
| Jan 2, 2007 | CFIT | CASE FILE IN TICRS | — |
| Oct 18, 2006 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 28, 2003 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 4, 2001 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 11, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 22, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 7, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2000 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 6, 2000 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 1, 2000 | DOCK | ASSIGNED TO EXAMINER | — |